A joint venture

GSK Consumer Healthcare has closed its transaction with Pfizer Consumer Healthcare in the UK and Ireland, creating a new joint venture under the name GSK Consumer Healthcare, the company has announced.

Since its launch on 27 April 2020, the new business has been working to bring together the two legacy teams and establish GSK Consumer Healthcare as a single operational entity. It aims to deliver global leadership across a broad spectrum of therapeutic areas and establish a strong combined OTC portfolio for customers, including brands such as Sensodyne, Voltarol, Panadol, Corsodyl, Anadin, Centrum and Nexium.

Commenting on the joint venture, area general manager Jon Workman said: “We are embarking on a long-term self care movement with the aim of sustaining a shift in the behaviours of the nation – getting people to think pharmacist first and avoid unnecessary visits to the GP and A&E in the longer term.”
GSK Health Partner

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Training Matters's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.